Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Propranolol vs Fractional CO2 Laser + Topical Timolol for Infantile Hemangioma
NCT07560332Completed
- Sponsor
- Cairo University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of timolol in infantile hemangioma (IH) (2 arms), sponsored by Cairo University. Primary endpoint: Global Assessment Score of Infantile Hemangioma at 3 months. Started Jan 2025; status: completed.
02
Drugs
timolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT07560332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07560332.